confirmation for Rymed's technology as he has left a multi decade career at a major competitor to join RyMed. Paul becomes the Chairman of the AVA (The American Vascular Association) later this year. The company will be using the proceeds of this funding on SG&A and building the sales force. The company also brought on as a new